Psychometric properties of the Brief Mishel Uncertainty in illness scales for patients with advanced cancer and their family caregivers
Abstract
BACKGROUND: This study comprehensively examined the psychometric properties of the Brief Mishel Uncertainty in Illness Scale for patients (MUIS-P) managing advanced cancer and their caregivers (MUIS-Cg).
METHODS: The MUIS-P and MUIS-Cg scales were developed based on the Mishel Uncertainty in Illness Scale-Adult. We conducted a secondary analysis to test the acceptability, factor structure, reliability, and validity of the brief uncertainty scales for patients with advanced cancer (N = 484) and their caregivers (N = 484) using data from a randomized clinical trial.
RESULTS: The 9-item MUIS-P and MUIS-Cg show goodness of fit for a two-factor structure (unpredictability and ambiguity) with adequate to acceptable internal consistency (Cronbach's alpha 0.66-0.78 for patients and 0.70-0.72 for caregivers and McDonald's omega 0.72-0.84 for patients and 0.76-0.79 for caregivers). The MUIS-P and MUIS-Cg scores correlated with negative appraisals of illness/caregiving, hopelessness, and avoidant coping, demonstrating convergent validity. The discriminant validity of the MUIS-P and MUIS-Cg was evidenced by their significant correlations with self-efficacy and active coping. The baseline MUIS-P and MUIS-Cg scores were significantly associated with quality of life, hopelessness, depression, distress, and avoidant coping at the 3-month follow-up, indicating their strong predictive validity.
CONCLUSION: This study comprehensively evaluated the psychometric properties of the MUIS-P and…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 484 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.